Free Newsletter
ALSO NOTED: J&J recalls balloon catheters; Dr. Reddy's stock tanks on loss;
> Johnson & Johnson is recalling 132,000 balloon catheters used to expand blood vessels after it determined that problems with them could cause injury or death; there have been no reported deaths, however. Report
> Dr. Reddy's stock took a tumble in India after the company reported an unexpected $21.5 million loss on declining revenues in the most recent quarter. Report
> Kidnapped January 18, Nicholas Piramal executive Ashwini Bhatt was rescued by a special police task force on Saturday, and the gangs responsible have been identified. Report
> Consumer advocates are asking the FDA to pin more stringent warnings on the wrinkle-fighting drug Botox, citing "serious adverse reactions, including death." Report
> GlaxoSmithKline is the first of the UK's top companies to offer its employees the chance to invest their own pension funds. Report
> Glenmark Pharma got the FDA's clearance for its manufacturing plant in Baddi, India, which makes semi-solid products. Report
> Sanofi-Aventis announced that Japanese regulators cleared its clot-prevention drug Clexane. Report
And Finally... Too much coffee may worsen diabetes, according to a new study in Diabetes Care. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: